Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin.
D000241:Adenosine / Q000494:pharmacology; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D002454:Cell Differentiation; D003070:Coformycin / Q000031:analogs & derivatives* / Q000633:toxicity; D003208:Concanavalin A / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D003839:Deoxyadenosines / Q000494:pharmacology; D007156:Immunologic Memory / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D051381:Rats; D012263:Ribonucleosides; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology
D058892:Adenosine Deaminase Inhibitors; D003839:Deoxyadenosines; D012263:Ribonucleosides; D003208:Concanavalin A; D003070:Coformycin; D009700:Nucleoside Deaminases; D000241:Adenosine